Stocks & Investing
Fri, October 4, 2024
[ 12:00 AM ] - WOPRAI
Thu, October 3, 2024
[ 12:00 AM ] - WOPRAI
Wed, September 11, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 30, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 15, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 8, 2024
Tue, July 30, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 10, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 11, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 22, 2024
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 15, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 10, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 9, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 8, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 7, 2024
[ 12:00 AM ] - WOPRAI
Fri, April 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, April 10, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 9, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 21, 2024
[ 12:00 AM ] - WOPRAI
Wed, March 20, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 1, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024 Serge Belanger Reiterated (TRVI) at Strong Buy and Held Target at $8 on, Oct 4th, 2024
Serge Belanger of Needham, Reiterated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $8 on, Oct 4th, 2024.
Serge has made no other calls on TRVI in the last 4 months.
There are 4 other peers that have a rating on TRVI. Out of the 4 peers that are also analyzing TRVI, 0 agree with Serge's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Serge
- Faisal Khurshid of "Leerink Partners" Initiated at Buy and Held Target at $7 on, Monday, September 9th, 2024
- Oren Livnat of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $6 on, Friday, August 30th, 2024
- Ryan Deschner of "Raymond James" Initiated at Buy and Held Target at $9 on, Friday, August 30th, 2024
- Brandon Folkes of "Rodman & Renshaw" Initiated at Strong Buy and Held Target at $7 on, Thursday, June 13th, 2024
